Proteinuria in preeclampsia: is it important?
Abstract
Objectives: Our aim is to evaluate the laboratory results and proteinuria levels of preeclamptic women and their relationships to maternal and fetal outcomes.
Material and methods: One hundred preeclamptic pregnant women who gave birth in our clinic between 2013 and 2015 were included in our study retrospectively. The data collected from the patients included gestational week, age, gravidity, parity, abortus history, blood pressure, biochemical parameters, delivery method, maternal hospitalization time, cesarean indication, complications, blood products required, plasmapheresis use and dialysis need. The details about the newborns were recorded retrospectively. The relationships between preeclampsia signs and maternal and neonatal outcomes were analyzed. The protein amounts were analyzed via 24-hour collected urine analyses and spot urine analyses.
Results: A statistically significant positive correlation was observed between neonatal intensive care unit needs and proteinuria levels. Fetal growth restriction, respiratory distress syndrome and sepsis were observed as the level of proteinuria increased, but the result was not statistically significant. Eclampsia was observed only in patients with massive proteinuria, and it was statistically significant. An increase in cesarean sections, placental abruptions, antihypertensive drug needs and blood product replacement rates was observed as the amount of proteinuria increased in preeclamptic women, but the results were not statistically significant.
Conclusions: The severity of preeclampsia cannot be determined by the level of proteinuria. However, when massive proteinuria is detected, the clinician should be more cautious about maternal and fetal complications.
Keywords: Complicationspreeclampsiaproteinuria
References
- American College of Obstetricians and Gynecologists. 2013. Task Force on Hypertension in Pregnancy. ACOG Hypertension in Pregnancy Task Force. Washington, DC: American College of Obstetricians and Gynecologists.
- Hughes ec. Obstetric terminology. In: Mitchell Perry H Jr, editor. Lifelong management of hypertension. Springer Science and Business Media, Philadelphia 1972: 442–423.
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology. 2000; 183(1): s1–s22.
- Heart Lung and Blood Institute. 2000. Working Group report on high blood pressure in pregnancy. Bethesda(MD): National Institutes of Health.
- Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011; 25(4): 391–403.
- Başbuğ A, Başbuğ D, Ünlü BS, et al. Preeklampside Maternal Serum IL-2, IL-10 Konsantrasyonları ve Th1/Th2 Dengesi. Turkiye Klinikleri J Gynecol Obst. 2012; 22(1): 1–7.
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009; 33(3): 130–137.
- Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Williams Obstetric. 21 st Edition. McGraw-Hill, New York 2001: Chapter 24.
- Thornton CE, Makris A, Ogle RF, et al. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010; 37(4): 466–470.
- Dong X, Gou W, Li C, et al. Proteinuria in preeclampsia: Not essential to diagnosis but related to disease severity and fetal outcomes. Pregnancy Hypertens. 2017; 8: 60–64.
- Kim MiJ, Kim YN, Jung EJ, et al. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia? Obstet Gynecol Sci. 2017; 60(3): 260–265.
- Mateus J, Newman R, Sibai BM, et al. Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. Am J Perinatol Rep. 2017; 7(1): 49–58.
- Newman MG, Robichaux AG, Stedman CM, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003; 188(1): 264–268.
- Chan P, Brown M, Simpson JM, et al. Proteinuria in pre-eclampsia: how much matters? BJOG. 2005; 112(3): 280–285.
- Thangaratinam S, Coomarasamy A, O'Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009; 7: 10.
- von Dadelszen P, Payne B, Li J, et al. PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011; 377(9761): 219–227.
- Shennan AH, Waugh J. The measurement of blood pressure and proteinuria in pregnancy. In: Critchley HH, MacLean A, Poston L, Walker J. ed. Pre-eclampsia. RCOG Press, London (UK) 2003: 305–24.
- Nischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women. J Nat Sci Biol Med. 2014; 5(2): 255–260.
- Hypertension in pregnancy: diagnosis and management of hypertensive disorders during pregnancy. NICE National Institute for Health and Clinical Excellence clinical guideline., 2010.
- Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013; 3(1): 44–47.
- Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol. 2010; 115(2 Pt 1): 365–375.
- Bramham K, Poli-de-Figueiredo CE, Seed PT, et al. Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk women. PLoS One. 2013; 8(10): e76083.
